Papers
2
Total Citations
13
H-Index
2
About
Dr. Xiaoqiang Xue is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly in robotic-assisted oncology. His most impactful contribution is leading the first multicenter prospective randomized controlled trial comparing the novel KangDuo Surgical Robot-01 (KD-SR-01) system against the established da Vinci system for robot-assisted radical nephroureterectomy. This landmark 2024 study, which has already garnered 11 citations, demonstrates his commitment to evaluating emerging domestic robotic platforms, potentially expanding access to advanced surgical care. Dr. Xue also contributes to the critical understanding of intraoperative complications, as evidenced by his case report on managing pneumothorax during retroperitoneal laparoscopic partial nephrectomy in a lupus nephritis patient. His research addresses both the optimization of surgical robotics and the nuanced management of high-risk patients with renal cell carcinomas. By bridging the gap between technological innovation and clinical safety, Dr. Xue is shaping the future of urologic oncology, making robotic surgery more accessible and safer for diverse patient populations.
Research Focus
Key Achievements
Top Papers
- 1
- 2